Clinical trial
Induction Therapy Study in Live Donor Kidney Transplant Recipients With a…
NCT00275509 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00275509 |
|---|---|
| Title | Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch |
| Official title | Open Label Randomized Study of Thymoglobulin Versus Daclizumab Induction Therapies for the Reduction of Acute Rejection in Live Donor Kidney Transplant Recipients With a Positive Crossmatch |
| Lead sponsor | Johns Hopkins University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug, Other |
| Interventions | Thymoglobulin, Daclizumab, Plasmapheresis, Mycophenolate mofetil, Tacrolimus, Dexamethasone, Prednisone, Cytogam |
| Enrollment | 56 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jan 12, 2006 |
| Last update posted | Jan 18, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: